High-resolution comparative genomic hybridisation yields a high detection rate of chromosomal aberrations in childhood acute lymphoblastic leukaemia

被引:23
作者
Kristensen, TD
Wesenberg, F
Jonsson, OG
Carlsen, NT
Forestier, E
Kirchhoff, M
Lundsteen, C
Schmiegelow, K
机构
[1] Univ Copenhagen Hosp, Dept Pediat, DK-2100 Copenhagen, Denmark
[2] Aker Univ Hosp, Dept Pediat, Rikshosp, Oslo, Norway
[3] Univ Hosp, Dept Pediat, Reykjavik, Iceland
[4] Odense Univ Hosp, Dept Pediat, DK-5000 Odense, Denmark
[5] Univ Umea Hosp, Dept Pediat, S-90185 Umea, Sweden
关键词
comparative genomic hybridisation; acute lymphocytic leukaemia;
D O I
10.1034/j.1600-0609.2003.00072.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cytogenetic aberrations are of prognostic significance in childhood acute lymphoblastic leukaemias and a high detection rate could improve the biological understanding and classification of these diseases. Methods: Bone-marrow samples from 92 children with acute lymphoblastic leukaemia were studied by high-resolution comparative genomic hybridisation (HRCGH) using dynamic standard reference intervals that enhance both specificity and sensitivity in the detection of aberrations. Results: In 80 patients (87%) HRCGH revealed a total of 405 aberrations, mostly whole chromosome gains (n = 265) and partial losses (n = 80). The 25 leukaemias with a gain of more than five whole chromosomes by HRCGH harboured only 7% of all losses. With G-band karyotyping 59 patients (64%) had aberrations. HRCGH revealed more aberrations per patient than did G-band karyotyping (median: 3 vs. 1, P = 0.005), revealed aberrations in 27 of the 34 patients for whom the G-band karyotyping failed or was found to be normal, and specifically revealed more 9p losses (21% vs. 5%, P < 0.005), 12p losses (12% vs. 2%, P < 0.05) and 17q gains (11% vs. 1%, P < 0.01). Compared to the present study, the frequency of patients with aberrant karyotypes was significantly lower in previous conventional CGH studies (64% vs. 87%, P < 0.0001), as was the rate of partial aberrations per patient (1.1% vs. 1.7, P < 0.001), particularly with fewer 6q losses, 9p losses and 17q gains detected. Conclusion: HRCGH is superior to conventional CGH as an adjunct to G-band karyotyping as it detects recurrent aberrations at a significantly higher rate than both these techniques.
引用
收藏
页码:363 / 372
页数:10
相关论文
共 49 条
[1]   Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents [J].
Andersen, MK ;
Christiansen, DH ;
Kirchhoff, M ;
Pedersen-Bjergaard, J .
GENES CHROMOSOMES & CANCER, 2001, 31 (01) :33-41
[2]  
Bentz M, 1998, GENE CHROMOSOME CANC, V21, P172, DOI 10.1002/(SICI)1098-2264(199802)21:2<172::AID-GCC14>3.3.CO
[3]  
2-T
[4]  
BRYNDORF T, 1995, AM J HUM GENET, V57, P1211
[5]   QUANTITATIVE-ANALYSIS OF COMPARATIVE GENOMIC HYBRIDIZATION [J].
DUMANOIR, S ;
SCHROCK, E ;
BENTZ, M ;
SPEICHER, MR ;
JOOS, S ;
RIED, T ;
LICHTER, P ;
CREMER, T .
CYTOMETRY, 1995, 19 (01) :27-41
[6]   Isochromosome 17q in blast crisis of chronic myeloid leukemia and in other hematologic malignancies is the result of clustered breakpoints in 17p11 and is not associated with coding TP53 mutations [J].
Fioretos, T ;
Strömbeck, B ;
Sandberg, T ;
Johansson, B ;
Billström, R ;
Borg, Å ;
Nilsson, PG ;
Van Den Berghe, H ;
Hagemeijer, A ;
Mitelman, F ;
Höglund, M .
BLOOD, 1999, 94 (01) :225-232
[7]  
Forestier E, 1997, ACTA PAEDIATR, V86, P819
[8]   Improving outcome through two decades in childhood ALL in the Nordic countries:: the impact of high-dose methotrexate in the reduction of CNS irradiation [J].
Gustafsson, G ;
Schmiegelow, K ;
Forestier, E ;
Clausen, N ;
Glomstein, A ;
Jonmundsson, G ;
Mellander, L ;
Mäkipernaa, A ;
Nygaard, R ;
Saarinen-Pihkala, UM .
LEUKEMIA, 2000, 14 (12) :2267-2275
[9]   Comparative genomic hybridization as part of a new diagnostic strategy in childhood hyperdiploid acute lymphoblastic leukemia [J].
Haas, OA ;
Henn, T ;
Romanakis, K ;
du Manoir, S ;
Lengauer, C .
LEUKEMIA, 1998, 12 (04) :474-481
[10]  
Harbott J, 1989, Haematol Blood Transfus, V32, P121